Trials / Completed
CompletedNCT02850003
Absorption and Systematic Pharmacokinetics of Topically Applied IDP-120 Gel
A Phase 1b Open-Label Study Evaluating the Absorption and Systematic Pharmacokinetics of Topically Applied IDP-120 Gel in Subjects With Acne Vulgaris Under Maximal Use Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Bausch Health Americas, Inc. · Industry
- Sex
- All
- Age
- 9 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
Study designed to assess the safety and plasma PK of tretinoin and its metabolites from topically applied IDP-120 gel.
Detailed description
An Open-label study designed to assess the safety and plasma PK of tretinoin and its metabolites from topically applied IDP-120 gel.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IDP-120 Gel | Gel |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2016-10-01
- Completion
- 2016-11-01
- First posted
- 2016-07-29
- Last updated
- 2017-09-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02850003. Inclusion in this directory is not an endorsement.